Financhill
Back

Sarepta Therapeutics Vs. JinkoSolar Holding Industry Stock Comparison

Sell
36

SRPT
Sarepta Therapeutics

Last Price:
$118.99
Seasonality Move:
12.18%
Sell
45

JKS
JinkoSolar Holding

Last Price:
$23.77
Seasonality Move:
4.61%
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $118.97. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
JinkoSolar Holding (JKS) is a Sell

Is JinkoSolar Holding a Buy, Sell or Hold?

  • The current JinkoSolar Holding [JKS] share price is $23.80. The Score for JKS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • JKS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $118.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

JKS Stock Price Chart

What is JinkoSolar Holding's stock price today?

  • The JinkoSolar Holding share price today is $23.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JKS is experiencing slight buying pressure.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 43.28 Sell
Chaikin Money Flow: -1117882 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.92 - 130.54) Sell
Bollinger Bands (100): (118.37 - 135.77) Sell

JKS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 44.65 Sell
Chaikin Money Flow: 307045 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.96 - 27.14) Sell
Bollinger Bands (100): (18.89 - 25.67) Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 123.1 Sell
20-day SMA: 125.31 Sell
50-day SMA: 122.99 Sell
200-day SMA: 129.64 Sell
8-day EMA: 122.43 Sell
20-day EMA: 123.17 Sell
50-day EMA: 123.7 Sell
200-day EMA: 126 Sell

JKS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.2 Sell
20-day SMA: 25.34 Sell
50-day SMA: 24.01 Sell
200-day SMA: 23.22 Buy
8-day EMA: 25.53 Sell
20-day EMA: 25.36 Sell
50-day EMA: 24.3 Sell
200-day EMA: 24.65 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.75 per share, and an increase next year of $7.84 per share.

JinkoSolar Holding Earnings Growth & JKS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $10.50 per share, and an increase next year of $3.02 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

JinkoSolar Holding Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):